1,846
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Synthesis and biological evaluation of (3/4-(pyrimidin-2-ylamino)benzoyl)-based hydrazine-1-carboxamide/carbothioamide derivatives as novel RXRα antagonists

, , , , , , , , , , & show all
Pages 880-896 | Received 11 Nov 2019, Accepted 01 Mar 2020, Published online: 30 Mar 2020

References

  • Huang P, Chandra V, Rastinejad F. Retinoic acid actions through mammalian nuclear receptors. Chem Rev 2014;114:233–54.
  • Evans RM, Mangelsdorf DJ. Nuclear receptors, RXR, and the big bang. Cell 2014;157:255–66.
  • Chambon P. The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol Endocrinol 2005;19:1418–28.
  • Bourguet W, Vivat V, Wurtz JM, et al. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol Cell 2000;5:289–98.
  • Shulman AI, Larson C, Mangelsdorf DJ, Ranganathan R. Structural determinants of allosteric ligand activation in RXR heterodimers. Cell 2004;116:417–29.
  • Chandra V, Huang PX, Hamuro Y, et al. Structure of the intact PPAR-gamma-RXR-alpha nuclear receptor complex on DNA. Nature 2008;456:350–U333.
  • Cesario RM, Stone J, Yen WC, et al. Differentiation and growth inhibition mediated via the rxr: PPAR-gamma heterodimer in colon cancer. Cancer Lett 2006;240:225–33.
  • Szanto A, Narkar V, Shen Q, et al. Retinoid x receptors: X-ploring their (patho)physiological functions. Cell Death Differ 2004;11: S126–S143.
  • Germain P, Iyer J, Zechel C, Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 2002;415:187–92.
  • Altucci L, Leibowitz MD, Ogilvie KM, et al. RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Discov 2007;6:793–810.
  • Gianni M, Ponzanelli I, Mologni L, et al. Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases. Cell Death Differ 2000;7:447–60.
  • Alvarez R, Vaz B, Gronemeyer H, de Lera AR. Functions, therapeutic applications, and synthesis of retinoids and carotenoids. Chem Rev 2014;114:1–125.
  • Tanaka T, Suh KS, Lo AM, De Luca LM. P21waf1/cip1 is a common transcriptional target of retinoid receptors: Pleiotropic regulatory mechanism through retinoic acid receptor (rar)/retinoid x receptor (RXR) heterodimer and RXR/RXR homodimer. J Biol Chem 2007;282:29987–97.
  • Park EJ, Kondratyuk TP, Morrell A, et al. Induction of retinoid X receptor activity and consequent upregulation of p21WAF1/CIP1 by indenoisoquinolines in MCF7 cells. Cancer Prev Res 2011;4:592–607.
  • Cao X, Liu W, Lin F, et al. Retinoid X receptor regulates NUR77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting. Mol Cell Biol 2004;24:9705–25.
  • Tunctan B, Kucukkavruk SP, Temiz-Resitoglu M, et al. Bexarotene, a selective RXR alpha agonist, reverses hypotension associated with inflammation and tissue injury in a rat model of septic shock. Inflammation 2018;41:337–55.
  • Zhou H, Liu W, Su Y, et al. NSAID sulindac and its analog bind RXR alpha and inhibit RXR alpha-dependent AKT signaling. Cancer Cell 2010;17:560–73.
  • Wang GH, Jiang FQ, Duan YH, et al. Targeting truncated retinoid X receptor-alpha by CF31 induces TNF-alpha-dependent apoptosis. Cancer Res 2013;73:307–18.
  • Heck MC, Wagner CE, Shahani PH, et al. Modeling, synthesis, and biological evaluation of potential retinoid X receptor (RXR)-selective agonists: analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene) and 6-(ethyl(5,5,8,8-tetrahydronaphthalen-2-yl)amino)nicotinic acid (net-TMN). J Med Chem 2016;59:8924–40.
  • Xu D, Guo S, Chen Z, et al. Binding characterization, synthesis and biological evaluation of RXRalpha antagonists targeting the coactivator binding site. Bioorg Med Chem Lett 2016;26:3846–9.
  • de Lera AR, Bourguet W, Altucci L, Gronemeyer H. Design of selective nuclear receptor modulators: RAR and RXR as a case study. Nat Rev Drug Discov 2007;6:811–20.
  • Boehm MF, Zhang L, Zhi L, et al. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J Med Chem 1995;38:3146–55.
  • Gottardis MM, Bischoff ED, Shirley MA, et al. Chemoprevention of mammary carcinoma by lgd1069 (targretin): An RXR-selective ligand. Cancer Res 1996;56:5566–70.
  • de Vries-van der Weij J, de Haan W, Hu L, et al. Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein. Endocrinology 2009;150:2368–75.
  • Sato Y, Ramalanjaona N, Huet T, et al. The “phantom effect” of the rexinoid lg100754: structural and functional insights. PLoS One 2010;5:e15119.
  • Schrödinger Release 2015-1: LigPrep. New York (NY): Schrödinger, LLC; 2015.
  • Schrödinger Release 2015-1: Glide. New York (NY): Schrödinger, LLC; 2015.